The quality criteria imposed on several biochemicals are stringent, th
us, high-separation purification technology is important to downstream
processing. Affinity-based purification technologies are regarded as
the finest available, and each one differs in its purifying ability, e
conomy, processing speed and capacity. The most widely used affinity t
echnology is classical affinity chromatography, however, other chromat
ography-based approaches have also been developed, for example, perfus
ion affinity chromatography, hyperdiffusionTM affinity chromatography,
high-perfor mance affinity chromatography, centrifugal affinity chrom
atography, affinity repulsion chromatography, heterobifunctional ligan
d affinity chromatography and the various chromatographic applications
of 'affinity tails'. On the other hand, non-chromatographic affinity
technologies aim at high throughput and seek to circumvent problems as
sociated with diffusion limitations experienced with most chromatograp
hic packings. Continuous affinity recycle extraction, aqueous two-phas
e affinity partitioning, membrane affinity filtration, affinity cross-
flow ultrafiltration, reversible soluble affinity polymer separation a
nd affinity precipitation are all non-chromatographic technologies. Se
veral types of affinity ligands are used to different extents; antibod
ies and their fragments, receptors and their binding substances, avidi
n/biotin systems, textile and biomimetic dyes, (oligo)peptides, antise
nse peptides, cheIated metal cations, lectins and phenylboronates, pro
tein A and G, calmodulin, DNA, sequence-specific DNA, (oligo)nudeotide
s and heparin. Likewise, there are several support types developed and
used; natural, synthetic, inorganic and composite materials.